Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Voranigo
(vorasidenib)Orphan drugstandardServier Pharmaceuticals LLC
Isocitrate Dehydrogenase 1 Inhibitor [EPC]
12.1 Mechanism of Action Vorasidenib is a small molecule inhibitor that targets isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2) enzymes. In vitro, vo...
Browse all Prader-Willi syndrome due to imprinting mutation news →
View all Prader-Willi syndrome due to imprinting mutation specialists →